Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy.
Kalhan, A
Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. [electronic resource] - Purinergic signalling Jun 2012 - 265-74 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-9546
10.1007/s11302-011-9280-5 doi
Antineoplastic Agents--administration & dosage
Cell Line, Tumor
Drug Delivery Systems--methods
Gene Expression Regulation, Neoplastic--drug effects
Humans
Neuroendocrine Tumors--drug therapy
Purinergic P1 Receptor Agonists--pharmacology
Purinergic P1 Receptor Antagonists--pharmacology
Receptor, Adenosine A2A--biosynthesis
Receptor, Adenosine A2B--biosynthesis
Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. [electronic resource] - Purinergic signalling Jun 2012 - 265-74 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-9546
10.1007/s11302-011-9280-5 doi
Antineoplastic Agents--administration & dosage
Cell Line, Tumor
Drug Delivery Systems--methods
Gene Expression Regulation, Neoplastic--drug effects
Humans
Neuroendocrine Tumors--drug therapy
Purinergic P1 Receptor Agonists--pharmacology
Purinergic P1 Receptor Antagonists--pharmacology
Receptor, Adenosine A2A--biosynthesis
Receptor, Adenosine A2B--biosynthesis